Filing Details

Accession Number:
0000711377-18-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-01 18:11:22
Reporting Period:
2018-07-30
Accepted Time:
2018-08-01 18:11:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189001 H Thomas Reed Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-30 4,000 $16.82 17,373 No 4 M Direct
Common Stock Acquisiton 2018-07-30 6,000 $17.07 23,373 No 4 M Direct
Common Stock Acquisiton 2018-07-30 6,000 $21.50 29,373 No 4 M Direct
Common Stock Acquisiton 2018-07-30 6,000 $31.24 35,373 No 4 M Direct
Common Stock Disposition 2018-07-30 22,000 $80.41 13,373 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2018-07-30 4,000 $0.00 4,000 $16.82
Common Stock Common Stock (Right to Buy) Disposition 2018-07-30 6,000 $0.00 6,000 $17.07
Common Stock Common Stock (Right to Buy) Disposition 2018-07-30 6,000 $0.00 6,000 $21.50
Common Stock Common Stock (Right to Buy) Disposition 2018-07-30 6,000 $0.00 6,000 $31.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,000 2020-10-07 No 4 M Direct
28,000 2021-10-06 No 4 M Direct
22,000 2022-10-04 No 4 M Direct
16,000 2023-10-03 No 4 M Direct
Footnotes
  1. Options were granted 10/7/2010, have 10 year lives, and were fully vested in 2013
  2. Options were granted 10/6/2011, have ten year lives, and vested in 2014
  3. Options were granted 10/4/2012, have ten year lives, and were vested in 2015
  4. Options were granted 10/3/2013, have ten year lives, and vested in 2016